ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
Introduction Comirnaty (Pfizer) was registered by the TGA on 28 January 2022 for use as a booster in the 16–17 year age group. ATAGI now extends the recommendation of a booster dose to include all individuals aged 16-17 years. This clinical recommendation aims to maximise protection for this age group who are at a critical point in their secondary education […]
COVID-19 advice for parents, students and children
RrWatch for symptoms If your child is unwell – even with mild symptoms – you must keep them home and get them tested. If children have any symptoms, they should take a PCR (nose and throat swab) test or rapid antigen test (RAT). If symptoms continue your child should stay home and take another RAT or PCR […]